ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

EBV-Upregulated B7-H3 Inhibits NK cell-Mediated Antitumor Function and Contributes to Nasopharyngeal Carcinoma Progression

Chen, Haiwen; Duan, Xiaobing; Deng, Xiaohong; Huang, Yingping; Zhou, Xiang; Zhang, Shanshan; Zhang, Xiao; Liu, Pingjuan; Yang, Chaopin; Liu, Guojun; Ren, Qinqin; Xiong, Yan; Zhu, Bo*; Zhang, Jiexia*; Xiang, Tong*广州医学院; 广州中医药大学; 中山大学; 1
Cancer Immunology Research2023-6DOI: 10.1158/2326-6066.CIR-22-0374
3被引21阅读
引用收藏
分享

摘要

Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV)-associated epithelial malignancy characterized by the presence of prominent infiltration of lymphocytes, including natural killer (NK) cells. Although NK cells can directly target EBV-infected tumor cells without restriction by the MHC, EBV-positive (EBV thorn ) NPC cells often develop resistance mechanisms that allow them to evade immune surveillance by NK cells. Elucidating the mechanisms involved in EBV-induced NK-cell dysfunction will contribute to the design of novel NK cell-based immunotherapies to treat NPC. Herein, we confirmed that the cytotoxic function of NK cells was impaired in EBV thorn NPC tissues and found that EBV infection-induced expression of B7-H3 in NPC negatively correlated with NK-cell function. The inhibitory effect of EBV thorn tumor expression of B7-H3 on NK-cell function was clarified in vitro and in vivo. Mechanistically, activation of the PI3K/AKT/mTOR signaling pathway via EBV latent mem-brane protein 1 (LMP1) was responsible for EBV infection- induced upregulation of B7-H3 expression. In an NPC xenograft mouse model with adoptive transfer of primary NK cells, deletion of B7-H3 on tumor cells in combination with anti-PD-L1 treatment restored NK cell-mediated antitumor activity and significantly improved the antitumor efficacy of NK cells. On the basis of our findings, we conclude that EBV infection can inhibit NK cell-mediated antitumor function by inducing upre-gulation of B7-H3 expression and provide a rationale for NK cell-based immunotherapies in combination of PD-L1 blockade and overcoming the immunosuppression of B7-H3 to treat EBV-associated NPC.

学科与关键词

关键词
EPSTEIN-BARR-VIRUSEXPRESSIONPROTEINSMOLECULEGROWTHCANCERPD-L1LMP1
相关
加载中…
  • Epstein-Barr Virus Induces Lymphangiogenesis and Lympth Node Metastasis via Upregulation of VEGF-C in Nasopharyngeal Carcinoma
    Li, Deng-Ke; Chen, Xing-Rui; Wang, Li-Na; Wang, Jia-Hong; Wen, Yue-Ting; Zhou, Zi-Ying; Li, Ji-Ke; Liu, Jing-Xian; Cai, Lin-Bo; Zhong, Shui-Sheng; Lyu, Xiao-Ming; Damola, Faleti Oluwasijibomi; Li, Min-Ying; Zhang, Jing-Jing; Zeng, Yu-Mei; Wang, Qian-Li; Zhang, Qian-Bing; Lyu, Hao; Fu, Xiao-Yan; Wang, Wei; Li, Xin*; Huang, Zhong-Xi*; Yao, Kai-Tai*Molecular Cancer Research, 2022, 20(1): 161-175.被引 5
  • EBV-Encoded MicroRNA-BART17-3p Targets DDX3X and Promotes EBV Infection in EBV-Associated T/Natural Killer-Cell Lymphoproliferative Diseases
    Jin, Jin; Sun, Ting; Zhang, Man; Cheng, Jiali; Gu, Jia; Huang, Liang; Xiao, Min; Zhou, Jianfeng; Luo, Hui*Open Forum Infectious Diseases, 2023, 10(11): ofad516.被引 1
  • Activation of NF-(B by LMPI in NPC Cells Is Mediatedby a Pathway via Degradation of I(B(
    Yin Li Qun Iiao Wei Tang Min Gu Huan Hua Li Xiao Yan Cao Ya Cancer Research Institute; Hunan Medical University Changsha; Hunan; P R China2000全国肿瘤学术大会.
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Immunology Research
发表日期
2023-06
卷期
第 11 卷, 第 6 期
页码
830-846
DOI
10.1158/2326-6066.CIR-22-0374
语言
ENGLISH
成果收录
SCIE
资助标注
China Cord Blood Bank of Shandong Province; National Natural Science Foundation of China [81874129, 82172795, 82203640, 82103433]; China Postdoctoral Science Foundation [2022M710893]; Post-doctoral Startup Foundation of Guangzhou City; Guangdong Basic and Applied Basic Research Foundation [2020A1515110013]; Clinical Application and Translational Medicine Project of First Affiliated Hospital of Guangzhou Medical University [201515-gyfyy]; Beijing Medical and Health Foundation [B19116]; Livzon Pharmaceutical Group Inc.

作者

  • C

    Chen, Haiwen (第一作者)

    guangzhou med univ

  • D

    Duan, Xiaobing

    zhuhai peoples hosp

查看全部 15 位作者收起作者
  • D

    Deng, Xiaohong

    2 · guangzhou univ chinese med

  • H

    Huang, Yingping

    sun yat sen univ

  • Z

    Zhou, Xiang

    sun yat sen univ

  • Z

    Zhang, Shanshan

    sun yat sen univ

  • Z

    Zhang, Xiao

    sun yat sen univ

  • L

    Liu, Pingjuan

    1 · sun yat sen univ

  • Y

    Yang, Chaopin

    sun yat sen univ

  • L

    Liu, Guojun

  • R

    Ren, Qinqin

    guangzhou med univ

  • X

    Xiong, Yan

    guangzhou med univ

  • Z

    Zhu, Bo (通讯)

    third mil med univ, xinqiao hosp

  • Z

    Zhang, Jiexia (通讯)

    guangzhou med univ

  • X

    Xiang, Tong (通讯)

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417